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Gene expression profile in diabetic KK/Ta mice.
Background. To identify susceptibility genes for diabetic
nephropathy, GeneChip Expression Analysis was employed
to survey the gene expression profile of diabetic KK/Ta mouse
kidneys.
Methods. Kidneys from three KK/Ta and two BALB/c
mice at 20 weeks of age were dissected. Total RNA was ex-
tracted and labeled for hybridizing to the Affymetrix Murine
Genome U74Av2 array. The gene expression profile was com-
pared between KK/Ta and BALB/c mice using GeneChip ex-
pression analysis software. Competitive reverse transcription-
polymerase chain reaction (RT-PCR) was used to confirm the
results of GeneChip for a selected number of genes.
Results. Out of 12,490 probe pairs present on GeneChip,
98 known genes and 31 expressed sequence tags (ESTs)
were found to be differentially expressed between KK/Ta and
BALB/c kidneys. Twenty-one known genes and seven ESTs that
increased in expression and 77 known genes and 24 ESTs that
decreased in KK/Ta kidneys were identified. These genes are
related to renal function, extracellular matrix expansion and
degradation, signal transduction, transcription regulation, ion
transport, glucose and lipid metabolism, and protein synthe-
sis and degradation. In the vicinity of UA-1 (quantitative trait
locus for the development of albuminuria in KK/Ta mice), can-
didate genes that showed differential expression were identi-
fied, including the Sdc4 gene for syndecan-4, Ahcy gene for
S-adenosylhomocysteine hydrolase, Sstr4 gene for somatostatin
receptor 4, and MafB gene for Kreisler leucine zipper protein.
Conclusion. The gene expression profile in KK/Ta kidneys is
different from that in age-matched BALB/c kidneys. Altered
gene expressions in the vicinity of UA-1 may be responsible for
the development of albuminuria in diabetic KK/Ta mice.
The inbred mouse strain KK/Ta established in Japan as
a diabetic strain spontaneously exhibits type 2 diabetes
associated with fasting hyperglycemia, glucose intoler-
ance, hyperinsulinemia, mild obesity, dyslipidemia, and
proteinuria [1–4]. Renal lesions in KK/Ta mice closely re-
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semble those in human diabetic nephropathy. Glomeruli
of diabetic KK/Ta mice show diffuse and nodular enlarge-
ment of the mesangium with proliferation of mesangial
cells. Immunohistologic studies show an intense, specific
fluorescence for c -globulin in the enlarged mesangium
and nodules and along the capillary wall. Albumin excre-
tion in diabetic KK/Ta mice is demonstrably increased
several weeks after establishment of hyperglycemia and,
as in the human disease, presumably represents intact
leaking nephrons without overt reduction in the single
nephron glomerular filtration rate (GFR) [5–7]. There-
fore, KK/Ta mice may serve as a suitable model for the
study of type 2 diabetes and diabetic nephropathy in
humans.
Recently, we carried out a genome wide linkage anal-
ysis of KK/Ta alleles contributing to impaired glucose
metabolism, hyperinsulinemia, obesity, dyslipidemia and
nephropathy, using 93 microsatellite markers in 208
KK/Ta × (BALB/c × KK/Ta) F1 male backcross mice [8].
Genome-wide analysis of susceptibility loci for albu-
minuria with microsatellite-based chromosomal maps
showed a contributing KK/Ta locus with a significant link-
age with the interval on chromosome 2, which we desig-
nated as urinary albumin-1 (UA-1). There were several
potent candidate genes in the vicinity of these intervals.
To identify susceptibility genes for the development of
albuminuria in diabetic KK/Ta mice, changes of the gene
expression profile in KK/Ta kidneys were surveyed by
GeneChip Expression Analysis.
METHODS
Animals
Inbred mice for the present study were purchased from
CLEA Japan, Inc. (Tokyo, Japan). BALB/c female mice
were mated with KK/Ta males to produce the F1 hybrid
mice in the animal facility of Juntendo University. All
mice were weaned at 4 weeks and, from 6 weeks onward,
mice were individually housed in plastic cages with free
access to food (rodent pellet chow CE-2; 342.2 kcal/100 g,
containing 4.4% crude fat) and water throughout the ex-
perimental period. Only male mice were utilized in this
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Table 1. Sequences of primers for competitive reverse transcription-polymerase chain reaction (RT-PCR) and the size of PCR product
Gene Primers Size bp
Calbindin-D9K 5′-TCACCTGCTGTTCCTGTCTG-3′ 5′-TCGCCATTCTTATCCAGCTC-3′ 247
Cadherin 15 5′-GCCCTGAGTTCTTCAGCATC-3′ 5′-CCTCTGCAGCCTCCATAAAG-3′ 222
Azgp1 5′-CAAGCCACTGCATTTCTCAA-3′ 5′-ATCTCGCAACCAAACATTCC-3′ 233
14-3-3 theta 5′-CATTGAGCAGAAGACCGACA-3′ 5′-CATCGCCACAAGCTACTTCA-3′ 218
Adipsin 5′-TGCACAGCTCCGTGTACTTC-3′ 5′-CACCTGCACAGAGTCGTCAT-3′ 236
Spink3 5′-GCTTTTGCACCCAGATCTTC-3′ 5′-TTCGAATGAGGACAGGCTCT-3′ 250
70zpep 5′-ATAGCAACCCACACGACTCC-3′ 5′-TGCTCCAAATGTTACCACCA-3′ 221
Syndecan 4 5′-TGGGCAAGAAACCCATCTAC-3′ 5′-TCTCTCTCTCAGGCAGCACA-3′ 232
For each gene, the sequence on the left is for the forward primer.
study because KK/Ta male mice show a greater tendency
to develop type 2 diabetes mellitus than KK/Ta female
mice. All mice were maintained in the same room un-
der conventional conditions with a regular light cycle of
12 hours light/12 hours darkness, and the temperature
controlled at 24◦C ± 1◦C.
Phenotypic characterization
Glucose tolerance was assessed using the intraperi-
toneal glucose tolerance test (IPGTT) in mice at 20 weeks
of age. Glucose levels in blood obtained from the retro-
orbital sinus were measured using Glutest E (Kyoto
Daiichi Kagaku, Kyoto, Japan) at 0 (fasting blood glu-
cose level) and 120 minutes after intraperitoneal glucose
injection. Renal dysfunction was assessed by measuring
urinary albumin at 20 weeks of age using enzyme-linked
immunosorbent assay (ELISA) (Albuwell M) (Exocell,
Inc., Philadelphia, PA, USA) and all samples were
individually adjusted for creatinine excretion (Creatinine
Companion) (Exocell, Inc.). At 20 weeks of age, blood
pressure was measured by a noninvasive tail-cuff and
pulse transducer system (Softron BP-98A, Tokyo, Japan).
Tissues and RNA preparation
Three KK/Ta and two BALB/c male mice were sacri-
ficed at 20 weeks of age, the kidneys were dissected and
snap-frozen in liquid nitrogen. The tissues were stored
at −80◦C for total RNA extraction. The procedures de-
scribed in detail in the Affymetrix GeneChip Expres-
sion Analysis Manual (Affymetrix, Inc., Santa Clara,
CA, USA) were essentially followed. In brief, RNA
was extracted with TRIzol and approximately 20 lg of
RNA were used for cDNA synthesis (Superscript II Kit)
(Life Technologies, Rockville, MD, USA). Biotin-labeled
cRNA was produced through in vitro transcription of
cDNA (ENZO BioArray High Yield RNA Transcript
Labeling Kit) (Affymetrix). Fragmented cRNA (30 lg)
was hybridized to Affymetrix Murine Genome U74Av2
GeneChip in Affymetrix Fluidics Station 400. The ar-
rays were washed and stained according to supplied
protocols [9].
Data analysis
The GeneChip used contained several probe sets spe-
cific for murine housekeepers [b-actin, glyceraldehyde-3
Table 2. Mean phenotypic values at 20 weeks of age
KW/Ta BALB/c
(N = 3) (N = 2)
Body weight g 38.8 ± 1.7a 28.2 ± 1.2
Fasting blood glucose levels 112.0 ± 6.6a 76.0 ± 3.0
mg/dL
Blood glucose levels at 459.3 ± 65.7a 97.0 ± 5.0
120 minutes mg/dL
Urinary albumin lg/mL 244.2 ± 21.8b 42.6 ± 13.2
Urinary creatinine mg/dL 31.8 ± 1.0c 86.4 ± 5.5
Urinary albumin: creatinine 771.4 ± 78.0b 50.5 ± 18.6
ratio mg/g·Cr
Mean blood pressure mm Hg 95.0 ± 2.3 94.5 ± 1.2
Data are expressed as mean ± SEM.
Glucose levels were measured at 0 and 120 minutes after intraperitoneal glucose
injection.
aSignificantly higher than that of BALB/c (P < 0.05).
bSignificantly higher than that of BALB/c (P < 0.01).
cSignificantly lower than that of BALB/c (P < 0.005).
phosphate dehydrogenase (GAPDH), hexokinase, 5S
rRNA, and B1/B2 repeats of c -crystalline], which served
as positive controls. Several human, rat and yeast probe
sets on each array served as negative controls, and exter-
nally spiked bacterial bioB, bioC, bioD, and cre served as
positive hybridization controls. GeneChip was scanned
with the probe array scanner and the data analyzed by
Affymetrix GeneChip Expression Analysis software.
Methods for data analysis, sensitivity, and quantifica-
tion aspects have been extensively documented in the
Affymetrix GeneChip Analysis Technical Manual and
were described previously [10, 11]. Briefly, each tran-
script was represented by the use of 20 pairs of perfect
match (PM) and mismatch (MM) 25-mer oligonucleotide
probes. The PM probes were identical in sequence to
the gene, and MM probes contain a homomeric (base
transversion) mismatch at the central base position
of the oligomer. The MM probes act as specific controls
that allow the direct subtraction of cross-hybridization
signals. The number of instances in which the PM hy-
bridization signal was greater than the MM signal was
computed along with the average of the logarithm of
the PM:MM ratio (after background subtraction and
correction for noise) for each probe set. These values
were used to make a matrix-based decision concerning
the presence or absence of an RNA molecule. To deter-
mine the quantitative RNA abundance, the average of the
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Table 3. Genes up-regulated in KK/Ta mice
Gene name Function GeneBank# Fold change ch. cM
Up-regulated
Angiotensinogen Renin-angiotensin system AF045887 6.5 ± 1.8 8 68
Calbindin-D9K Calcium transport AF028071 17.3 ± 4.2 X UK
Cadherin15 Adhesion molecule AJ245402 13.8 ± 5.2 8 67
lntegrin alpha 7 Adhesion molecule L23423 4.6 ± 1.1 10 72
Sialyitransferase 8 Insulin resistance X84235 2.7 ± 0.2 6 60
Alpha-2-glycoprotein 1, zinc Lipid metabolism D44593 15.4 ± 2.9 5 78
Adipose differentiation related protein Adipose differentiation M93275 2.6 ± 0.2 4 38.9
Laminin, alpha 3 Structure protein X84014 7.6 ± 2.9 18 3
14-3-3 theta PKC signal transduction U56243 10.4 ± 6.2 12 UK
Formin-like Signal transduction AF006466 2.5 ± 0.3 11 UK
S-adenosylhomocysteine hydrolase Na(+) channels regulation BC0l5304 4.8 ± 0.9 2 89
ATPase 4a Ion transport U17282 4.1 ± 0.2 7 10
Hydroxysteroid 11-beta dehydrogenase 1 Cortisol metabolism X83202 3.4 ± 0.2 1 UK
Cytochrome c oxidase subunit VlaH Energy metabolism U08439 6.8 ± 0.8 7 61
Erythroid differentiation regulator Erythroid differentiation Al153421 2.1 ± 0.3 UK UK
Retinal degeneration 1 retinal degeneration C78850 4.7 ± 0.5 5 57
Cytidine 5′-triphosphate synthase 2 Nucleotide anabolic U49385 4.3 ± 0.8 X UK
Melanoma antigen Tumor antigen D10049 37.9 ± 18.3 UK UK
Mouse endogenous proviral superantigen Immunity M90535 15.5 ± 6.6 1 96
Retinol dehydrogenase type 5 Inflammation AF033195 9.9 ± 3.9 10 72
Membrane glycoprotein gene Immunity Z22552 6.6 ± 2.2 UK UK
Endogenous retrovirus truncated gag protein UK M26005 14.1 ± 3.9 UK UK
UI-M-BH1-amb-d-01-0.UI.s1 UK AW047207 9.1 ± 1.8 UK UK
2610042L04Rik UK AK011748 6.7 ± 2.0 UK UK
1110015E22Rik UK AK003726 6.2 ± 0.7 7 UK
1300017K07Rik UK AI838360 3.4 ± 0.7 11 UK
5830413E08Rik UK AI849939 3.1 ± 0.3 10 UK
Expressed sequence Al893585 UK AV080003 4.1 ± 0.9 12 UK
The fold changes are mean ± SEM of the six possible pair-wise comparisons between KK/Ta and Balb/c mice. Fold changes were calculated only for those genes
showing an increased or decreased fold (>2) in all six comparisons. UK is unknown.
differences representing PM minus MM for each gene-
specific probe family was calculated, after discarding the
maximum, the minimum, and any outliers beyond these
three SDs. To allow comparisons between any two experi-
ments, the GeneChip software conducted normalization
and scaling of the data for each array and pair-wise com-
parisons were made between KK/Ta and BALB/c mice.
Three arrays were used for KK/Ta mice and two arrays
for BALB/c mice and cross-compared, thus generating
six pair-wise comparisons. Fold changes were calculated
only for those genes showing an increased or decreased
call in at least five out of the six comparisons.
Competitive reverse transcription-polymerase
chain reaction (RT-PCR)
Competitive RT-PCR for a select number of genes was
carried out using the Quantum RNA kit following the
manufacturer’s instructions (Ambion, Inc., Austin, TX,
USA). Briefly, 1 lg of total RNA used in GeneChip
analysis was reverse transcribed with Superscript II
RNase H− reverse transcriptase (Life Technologies) us-
ing random decamers as downstream primers. The cDNA
obtained was further amplified by PCR with special
oligonucleotides as shown in Table 1. The PCR param-
eters were 30-second denaturation at 95◦C, 30-second
annealing at 56◦C, and 60-second extension at 72◦C for
25 to 33 cycles. A mixed ratio of 18S ribosomal RNA
primers and competimers (depending on the genes, usu-
ally primer:competimer ratios from 2:8 to 4:6) was used
to amplify rRNA as an internal control under the same
conditions as the genes of interest. The PCR products
were resolved on 2% agarose gel, stained with ethidium
bromide, and analyzed by VersaDocTM Imaging System
(Bio-Rad Laboratories Inc, Hercules, CA, USA).
Statistics
Data are expressed as mean ± SEM. Statistics analysis
was performed by Student unpaired t test. P < 0.05 was
considered to be significant.
RESULTS
Phenotypic characterization
As shown in Table 2, KK/Ta mice showed obesity, fast-
ing hyperglycemia, and impaired glucose tolerance com-
pared with the findings in normal control BALB/c mice.
The mean body weight of KK/Ta mice was greater than
that of BALB/c mice (P < 0.05). Fasting blood glucose
levels and blood glucose levels at 120 minutes in IPGTT
of KK/Ta mice were significantly higher than those of
BALB/c mice (P < 0.05). The level of the mean urinary
albumin in KK/Ta mice was markedly higher than that
in BALB/c mice at 20 weeks of age (P < 0.01). How-
ever, the mean blood pressure of KK/Ta mice was almost
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Table 4. Genes down-regulated in KK/Ta mice
Gene name Function GeneBenk# Fold change ch. cM
Down-rugulated
Chordin TGF-b signal AF069501 4.0 ± 0.7 16 14
TNF-induced protein 2 TNF signal L24118 3.5 ± 0.4 12 56
TNF receptor-associated factor 6 TNF signal D84655 3.6 ± 0.9 2 UK
Phosphoprotein enriched in astrocytes 15 TNF signal L31958 6.9 ± 2.6 1 93.8
Prostaglandin E receptor EP1 PGE signal Y07611 4.8 ± 2.3 8 38
FMS-like tyrosine kinase 1 VEGF receptor D88690 4.1 ± 1.0 5 82
Cholecystokinin Gut hormone X71422 2.7 ± 0.2 9 71
Prolactin receptor related sequence 1 Gonadal hormone signal M22957 2.7 ± 0.4 UK UK
Adipsin Lipid metabolism X04673 14.8 ± 7.2 10 43
Phosphotidylinositol transfer protein, beta Phospholipid metabolism U46934 8.6 ± 3.4 5 UK
Resistin Lipid metabolism AC087183 8.4 ± 4.3 8 UK
Mevalonate kinase Cholesterol biosynthesis AF137598 3.8 ± 0.9 5 64
Apolipoprotein E Lipoprotein metabolism X05830 2.6 ± 0.3 7 4
HMG-CoA reductase Lipoprotein metabolism BC026554 2.5 ± 0.2 13 49
Group specific component Glucose metabolism M55413 4.9 ± 1.8 5 44
Adenine phosphoribosyl transferase Nucleotide metabolism M11310 7.9 ± 3.9 8 67
Cathepsin H Cysteine proteinase U06119 2.5 ± 0.1 9 50
Aldh3a1 Aldehyde dehydrogenase AF072815 5.3 ± 2.6 11 34.2
Aldh5a1 Aldehyde dehydrogenase AL589699 3.2 ± 0.4 4 66.1
Aldo-keto reductase family 1, member E1 Aldo-keto reductase U68535 4.7 ± 1.6 UK UK
Aldo-keto reductase family 1, member B7 Aldo-keto reductase J05663 3.9 ± 0.7 6 14
Cytochrome P450, 1b1 Xenobiotic enzyme X78445 4.6 ± 1.1 17 UK
Sialytransferase 7 F Glycosylation enzyme AB035174 4.1 ± 0.9 2 UK
Gamma-glutamyl carboxylase Coagulation enzyme AF087938 5.1 ± 1.9 6 UK
Serine protease inhibitor, Kazal type 3 Trypsin inhibitor X06342 60.0 ± 14.3 18 UK
Ddef1 Adhesion molecule AF075461 2.8 ± 0.5 15 UK
H2B and H2A histone genes Structure protein X05862 6.9 ± 1.3 13 UK
H2B histone family, member S Structure protein AK005191 5.5 ± 1.2 13 UK
Small proline-rich protein 2C Structure protein AJ005561 5.5 ± 2.2 3 45.2
Cyclic nucleotide gated channel 4 Ion channel U49391 4.0 ± 1.5 X UK
Potassium channel Kcnk4 Ion channel AF056492 4.0 ± 1.2 19 4.5
Transthyretin Retinol carrier protein D00073 6.8 ± 3.6 18 7
Transcription factor junB Transcription factor U20735 5.4 ± 0.6 8 38.6
Mafk Transcription factor 042124 3.5 ± 1.5 5 81
Metallothionein-I activator Transcription factor AK003023 3.2 ± 0.2 X UK
SRY-box containing gene 17 Transcription factor D49473 3.1 ± 0.5 1 7
Homeo box D11 Transcription factor D00466 2.6 ± 0.3 2 45
Hpalltiny fragments 9c Transcription factor X05830 2.5 ± 0.2 16 10.9
Leukemia-associated gene Transcriptional regulation AK002606 4.5 ± 1.1 4 65.7
Protein tyrosine phosphatase PEP Signal transduction M90388 18.6 ± 8.2 3 UK
Protein tyrosine phosphatase Ptprl Signal transduction D88187 8.9 ± 4.0 4 UK
Opioid growth factor receptor Signal transduction AF303894 7.8 ± 3.2 2 UK
Zeta-chain associated protein kinase Signal transduction U04379 6.1 ± 3.0 1 20.5
Tetratricopeptide repeat domain Signal transduction AB008516 5.2 ± 1.8 16 67.9
Sh3kbp1 binding protein 1 Signal transduction AF246218 4.9 ± 1.7 UK UK
Guanine nucleotide binding protein Signal transduction U29055 4.8 ± 0.3 4 79.4
ADP-ribosylation-like 4 Signal transduction Y12577 4.7 ± 1.1 12 25
Adenylyl cyclase-associated protein Signal transduction L12367 4.3 ± 1.0 4 UK
Lymphocyte protein tyrosine kinase Signal transduction BC011474 3.4 ± 0.3 4 50
C-met-related tyrosine kinase Signal transduction X74736 2.9 ± 0.3 9 60
Adenomatosis polyposis coli Signal transduction M88127 2.8 ± 0.1 18 15
Caseinolytic protease X Signal transduction AA013832 2.7 ± 0.4 9 36.5
IGFBP3 Growth factor X81581 7.6 ± 4.2 11 1.4
Somatostatin receptor 3 Growth factor receptor M91000 6.7 ± 2.9 15 46.3
Inhibin alpha Growth/differentiation X55957 4.8 ± 1.7 1 41.6
Midkine growth factor M34094 3.4 ± 0.9 2 53
Fibroblast growth factor receptor 2 Gowth factor M63503 3.4 ± 0.6 7 63
Growth arrest specific 2 Growth factor M21828 4.5 ± 0.5 7 26.8
Keratin complex 1, acidic, gene 5 Epithelial differentiation X65506 14.4 ± 6.3 11 UK
Keratin complex 1, acidic, gene 3 Epithelial differentiation X75650 4.3 ± 1.6 11 59
Keratincomplex 1, acidic, gene 14 Epithelial differentiation J02644 3.5 ± 2.0 11 58.6
Oocyte maturation, beta Oocyte maturation AA692915 4.6 ± 1.2 9 43
Wnt8a Development signal Z68889 2.8 ± 0.4 18 UK
Polymerase Pole4 DNA replication AK010135 9.6 ± 3.4 6 UK
Geminin DNA replication inhibition AF068780 3.3 ± 0.7 13 UK
Nth (endonuclease III)-like 1 DNA repair enzyme Y09688 3.1 ± 0.7 17 UK
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Table 4. (Continued)
Gene name Function GeneBenk# Fold change ch. cM
Cpsf4 RNA metabolism AF033201 3.1 ± 0.7 5 UK
Cannabinoid receptor 1 Neuroprotection U17985 3.8 ± 0.2 4 13.9
GABA-A receptor, subunit beta 3 Neurotransmitter U14420 3.3 ± 0.4 7 28.6
Hypocretin Neuropeptide AF019566 3.2 ± 0.5 11 61.2
Chromogranin A Active peptides precursor AV371732 2.4 ± 0.2 12 48
H2-Ea Immunity AF050157 14.1 ± 5.8 17 18.7
H2-D4 Immunity X52914 3.4 ± 0.7 17 19.1
T-cell, immune regulator 1 Immunity AB022322 4.1 ± 1.7 19 6
Complement component 4 Immunity AF049850 3.7 ± 0.5 17 18.8
Lymphocyte antigen 6 complex Immunity X70920 2.7 ± 0.4 15 UK
Interleukin 9 receptor Inflammation M84746 4.5 ± 1.4 11 UK
Genethonin 1 UK AW124049 7.2 ± 2.9 5 52
Arpc5 UK AK008097 3.3 ± 0.5 12 UK
0610005C13Rik UK AI182092 21.9 ± 6.1 7 UK
1200007D18Rik UK AK003239 14.7 ± 6.1 17 UK
0610012A05Rik UK AK002572 13.4 ± 6.1 15 UK
2310016E22Rik UK AK009385 7.3 ± 2.8 12 UK
2610002J02Rik UK AK003268 5.2 ± 2.1 UK UK
1110020E07Rik UK AK003853 5.2 ± 2.0 1 UK
1810054D07Rik UK AK007856 5.2 ± 1.5 4 UK
9530019H02Rik UK AA04199 4.0 ± 1.1 UK UK
0610038L10Rik UK AF031380 3.7 ± 1.3 19 UK
3110079A16Rik UK AK014259 3.0 ± 0.4 UK UK
9130009C22Rik UK AF374384 3.0 ± 0.4 2 UK
4930524H12Rik UK AK006083 3.0 ± 0.3 17 UK
4432417F03Rik UK AK014501 2.8 ± 0.5 6 UK
503140lC21Rik UK AK019863 2.4 ± 0.2 UK UK
Hypothetical protein MGC27546 UK AI853439 11.2 ± 1.8 9 UK
Hypothetical gene BC006054 UK AI837948 4.5 ± 3.3 11 UK
Hypothetical protein MGC28705 UK AI327166 2.9 ± 0.4 UK UK
D8Wsu96e UK AW125538 4.0 ± 1.5 8 34.5
DKFZp586P0123.1 UK AW122431 3.9 ± 0.5 7 UK
RP23-20C9 UK AI842277 3.3 ± 0.3 11 UK
Expressed sequence UK AV35651 2.9 ± 0.5 19 UK
Wayne State University 114 UK AA409579 2.9 ± 0.3 4 76.4
The fold changes are mean ± SEM of the six possible pair-wise comparisons between KK/Ta and Balb/c mice. Fold changes were calculated only for those genes
showing an increased or decreased fold (>2) in all six comparisons. UK is unknown.
the same as that of BALB/c mice (95.0 ± 2.3 mm Hg vs.
94.5 ± 1.2 mm Hg, respectively).
Comparison of gene expression profiles between
KK/Ta and BALB/c mice
Genes showing increased or decreased calls in all six
comparisons and all six folds >2 were selected (Tables 3
and 4). Out of 12,490 probe pairs present on GeneChip,
we identified 98 known genes and 31 expressed sequence
tags (ESTs) differentially expressed in the kidneys of
KK/Ta mice and BALB/c mice. Twenty-one known genes
and seven ESTs were up-regulated and 77 known genes
and 24 ESTs were down-regulated in KK/Ta mice versus
BALB/c mice.
Candidate genes contributing to the development
of albuminuria in diabetic KK/Ta mice
The interval closely linked to UA-1 contains sev-
eral interesting candidate genes, including the Hnf3b
gene for hepatocyte nuclear factor 3b, Ahcy gene for
S-adenosylhomocysteine hydrolase, and Sdc4 gene for
syndecan-4. The fold changes of these genes are shown
in Figure 1. Fold changes were calculated only for those
genes showing an increased or decreased call in at least
five out of the six comparisons. Values are mean ± SEM.
Competitive RT-PCR
GeneChip results were confirmed by competitive
RT-PCR for four up-regulated genes, three down-
regulated genes and a gene in the vicinity of UA-1. The
RT-PCR results showed a similar pattern to those from
GeneChip analysis, indicating a siginificant elevation in
gene expression for Calbindin-D9K, Cadherin15, Azgp-
1, 14-3-3 theta, and Sydecan4, and decreased expression
for Adipsin, Spink3, and 70zpep in KK/Ta mice versus
BALB/c mice.
DISCUSSION
To identify the candidate genes responsible for
nephropathy in diabetic KK/Ta mice, we employed
GeneChip Expression Analysis to screen genes that
are expressed differently in kidneys of KK/Ta mice
and BALB/c mice. Using Affymetrix Murine Genome
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Fig. 1. Quantitative trait locus (QTL) analysis of the sum of urinary albumin levels in KK/Ta × (BALB/c × KK/Ta) F1 backcross mice at 20 weeks
and 28 weeks of age. Logarithm of odds (LOD) score curves are shown along chromosomes. The sum of urinary albumin levels showed a significant
linkage with the interval at 83.0 cM close to the marker D2Mit311 with a maximum LOD of 3.5 (v 2 = 13.2, P = 0.0003). The number on the
top of the vertical line represents the LOD score. Mapping positions of the typed microsatellite markers are indicated on the left with the Mouse
Chromosome Committee cM distances from the centromere in parentheses. The potential candidate genes contained in the support interval are
shown on the right side. Fold changes were calculated only for those genes showing an increased or decreased call in at least five out of the six
comparisons. Symbol is: –, decreased renal expression in KK/Ta mouse. Rends is the QTL responsible for the renal disease in (New Zealand Black ×
New Zealand White) F1 hybrid mouse model of systemic lupus erythematosus.
U74Av2 GeneChip, 12,490 genes have been simulta-
neously screened, which enables us to delineate various
biosynthetic or signaling pathways involved in nephropa-
thy of KK/Ta mice. Out of 12,490 probe pairs present
on GeneChip, 98 known genes and 31 ESTs were
found to be differentially expressed between KK/Ta and
BALB/c kidneys. These genes are related to renal func-
tion, extracellular matrix expansion and degradation, sig-
nal transduction, transcription regulation, ion transport,
glucose and lipid metabolism, and protein synthesis and
degradation. Several of them, including 14-3-3 theta and
Cytochrome P450, have been reported previously for dif-
ferential expression in diabetes or diabetic nephropathy
[12, 13].
The body weight of KK/Ta mice was significantly
greater than that of age-matched BALB/c mice from
4 weeks of age. The levels of fasting blood glucose and
blood glucose at 120 minutes in IPGTT were markedly
increased in KK/Ta mice from 8 weeks of age. Urinary
albumin excretion level tended to increase in KK/Ta
mice at 8 weeks of age (data not shown). At the age of
20 weeks, KK/Ta mice already showed obesity, fasting hy-
perglycemia, impaired glucose tolerance, and albumin-
uria. Therefore, differential expression of some genes
and ESTs may result not only from genetic disposition
but also from obesity, hyperglycemia, and proteinuria.
However, the genes we identified will be helpful in find-
ing candidate genes contributing to diabetic nephropa-
thy. Further studies should include an investigation of
time-course expression and localization of these genes
using isolated glomeruli and cultured mesangial and
tubular cells. In addition, functional linkage between the
altered expression of these genes and diabetic nephropa-
thy should be examined, since differentially expressed
genes may simply reflect differences between strains
rather than molecular events in the progression of dia-
betic nephropathy.
In a previous study, we identified the susceptibility
locus contributing to the development of albuminuria in
diabetic KK/Ta mice on chromosome 2, and designated it
UA-1 [abstract; Shike T et al, J Am Soc Nephrol 11:414A,
2000]. The interval closely linked to UA-1 contains sev-
eral interesting candidate genes, including the Sdc4 gene
for syndecan-4, Ahcy gene for S-adenosylhomocysteine
hydrolase, Ada gene for adenosine deaminase, Ghrh gene
for growth hormone-releasing hormone (GHrH), Sstr4
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Fig. 2. Results of competitive reverse transcription-polymerase chain reaction (RT-PCR). The upper bands are competitors (489 bp), and the lower
bands are genes of interest. The gels illustrated are representative of three KK/Ta mice (K) and two BALB/c mice (B).
gene for somatostatin receptor 4, and MafB gene for
Kreisler leucine zipper protein.
Syndecan-4 (Ryudocan) is a type I intergral mem-
brane heparan sulfate proteoglycan (HSPG). A
previous study demonstrated that it is expressed in
various tissues, and its level of expression in the kidney
is stronger than those of other syndecan family members
[14]. Syndecan-4 has been implicated in growth-factor
binding, cell-extracellular matrix adhesion and tissue
damage responses [15]. It has been proposed as an
early response gene in vascular injury [16]. Recently,
it has been shown that syndecan-4 mRNA and protein
levels are markedly elevated in human proliferative
but not in nonproliferative glomerular diseases [17].
The gene expression of syndecan-4 in KK/Ta mouse
kidneys was more significantly up-regulated than that
in age-matched BALB/c mouse kidneys (fold change
26). The consequences of syndecan-4 up-regulation are
not completely understood, but it appears now that
syndecan-4 is involved in signaling transduction. It can
interact, in combination with the inositol phospholipid
PIP2, with serine/threonine kinase protein kinase C
(PKC) a, b , and c . It has also been shown that growth
factors may regulate the ability of syndecan-4 to bind
and activate PKC [18]. Thus syndecan-4 may be one of
the potential candidate genes responsible for diabetic
nephropathy.
Ahcy (S-adenosylhomocysteine hydrolase) is a key en-
zyme in the S-adenosylhomocysteine-dependent methy-
lation reaction. Adenosine is an obligatory product of
this pathway [19]. In a paracrine manner, adenosine
mediates several responses on glomerular cells bearing
adenosine receptors. Reported responses include modu-
lation of mesangial cell growth [20, 21], mesangial cell
contraction [22], afferent arteriolar constriction [23],
inhibition of renin release [24], and modulation of the
tubuloglomerular feedback response [25]. Ada (adeno-
sine deaminase) is also relevant to adenosine metabolism
[26]. Both Ahcy and Ada transcripts were differen-
tially expressed between KK/Ta and BALB/c kidneys.
These results suggested that turnover of the adenosine
metabolic cycle may be impaired in KK/Ta mouse kidneys
and this disturbance might be related to the development
of albuminuria.
Somatostatin and GHrH are thought to play major
competitive roles in growth control. It has been shown
that therapy with octreotide (somatostatin analogue) de-
creases the GFR and the effective renal plasma flow in
Fan et al: Gene expression profile in diabetic KK/Ta mice 1985
patients with type 1 diabetes and renal hyperfiltration
[27]. It was speculated that octreotide reduces GFR by
suppression of GHrH [28]. Thus, both Ghrh and Sstr4 are
potential candidate genes for diabetic nephropathy.
MafB (Kreisler leucine zipper protein) is a transcrip-
tion factor of the Maf subfamily. The mouse MafB gene
is essential for differentiation of glomerular podocytes.
Mice homozygous for the MafB mutation show protein-
uria, as well as fusion and effacement of podocyte foot
processes [29, 30].
Differentially expressed genes in the vicinity of UA-1
provided us with a new clue to identify the candidate gene
responsible for the development of diabetic nephropathy.
To identify the candidate gene for the development of
albuminuria in diabetic KK/Ta mice, studies will be con-
tinued, including Northern blotting, DNA sequence anal-
ysis, single-strand conformation polymorphism (SSCP),
and an investigation of functional linkage, in the future.
APPENDIX
Abbreviations used in this article are: Azgp1, alpha-2-glycoprotein
1 zinc; Spink3, serine protease inhibitor, Kazal type 3; 70zpep, pro-
tein tyrosine phosphatase PEP; Aldh3a1, aldehyde dehydrogenase
family 3, subfamily A1; Aldh5a1, aldehyde dehydrogenase family 5, sub-
family A1; Ddef1, development and differentiation enhancing; Mafk,
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K;
IGFBP3, insulin-like growth factor binding protein 3; Wnt8a, wingless-
related MMTV integration site 8A; Cpsf4, cleavage and polyadenyla-
tion specific factor 4; H2-Ea, histocompatibility 2, class II antigen E
alpha; H2-D4, histocompatibility 2, D region locus 4; Arpc5, actin-
related protein 2/3 complex, subunit 5.
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